Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	359	243	418	874	719	875
Market Cap Growth	-38.67%	-41.95%	-52.16%	21.63%	-17.89%	-36.14%
Enterprise Value	-32	-138	-40	451	362	576
PE Ratio	-	96.77	66.65	26.37	30.79	7.58
PS Ratio	2.00	1.26	1.64	3.25	2.90	3.85
PB Ratio	0.65	0.45	0.79	1.73	1.59	2.13
P/FCF Ratio	-20.09	19.55	13.36	13.73	14.38	19.48
P/OCF Ratio	-20.68	18.97	13.08	13.61	13.88	19.05
EV/Sales Ratio	-0.85	-0.72	-0.16	1.68	1.46	2.53
EV/EBITDA Ratio	-212.59	-14.81	-2.84	9.98	10.50	18.03
EV/EBIT Ratio	39.23	-21.84	-3.53	10.65	11.45	19.83
EV/FCF Ratio	12.84	-11.15	-1.27	7.09	7.25	12.81
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.03	0.03
Debt / EBITDA Ratio	9.16	0.75	0.63	0.22	0.33	0.39
Debt / FCF Ratio	-0.55	0.56	0.28	0.16	0.23	0.28
Quick Ratio	4.62	4.82	5.47	6.25	6.03	5.69
Current Ratio	4.71	4.94	5.68	6.43	6.21	5.95
Asset Turnover	0.28	0.30	0.41	0.47	0.49	0.54
Return on Equity (ROE)	-0.90%	0.50%	1.20%	6.80%	5.40%	33.30%
Return on Assets (ROA)	-0.80%	0.40%	1.00%	5.80%	4.60%	27.50%
Return on Capital (ROIC)	-4.58%	-1.00%	0.66%	6.41%	4.32%	21.45%
Earnings Yield	-1.37%	1.03%	1.50%	3.79%	3.25%	13.20%
FCF Yield	-3.31%	5.11%	7.49%	7.28%	6.95%	5.13%
Buyback Yield / Dilution	-0.63%	-1.01%	-0.11%	-3.14%	-0.63%	-3.40%
Total Shareholder Return	-0.63%	-1.01%	-0.11%	-3.14%	-0.63%	-3.40%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).